home / stock / ixhl / ixhl news


IXHL News and Press, Incannex Healthcare Limited

Stock Information

Company Name: Incannex Healthcare Limited
Stock Symbol: IXHL
Market: NASDAQ
Website: incannex.com.au

Menu

IXHL IXHL Quote IXHL Short IXHL News IXHL Articles IXHL Message Board
Get IXHL Alerts

News, Short Squeeze, Breakout and More Instantly...

IXHL - Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

NEW YORK and MELBOURNE, Australia, May 30, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies is ple...

IXHL - Expected earnings - Incannex Healthcare Inc.

Incannex Healthcare Inc. (IXHL) is expected to report for Q3 2024

IXHL - Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

MELBOURNE, Australia and NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company, is pleased to announce the successful completion of a pre-IND (Investig...

IXHL - Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Dallas, Texas--(Newsfile Corp. - May 1, 2024) - Stonegate Healthcare Partners is pleased to announce the publication of its latest report, titled "Potentially Transformative therapies for Generalized Anxiety Disorder (GAD)." This report explores the pervasive issue of GAD, a condition affecting m...

IXHL - Incannex Healthcare Inc. Quarterly Update, Q1 2024

MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Inc. (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide quarterly activities update and for the quarter ended 31 March 2024...

IXHL - US Companies Moving the Markets, Evening edition
Tue, Mar 19, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 9.8% to $0.133 on volume of 209,262,975 shares Ontrak Inc. (OTRK) rose 131.6% to $0.44 on volume of 206,699,914 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.7% to $3.65 on volume of 1...

IXHL - Watching Biotech and Life Science Stocks

2024-03-11 10:10:00 ET March 11, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech and Transportation sectors. The newest biotech companies focus on cancer treatments ...

IXHL - US Companies Moving the Markets, Morning edition
Thu, Feb 29, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Marathon Digital Holdings Inc. (MARA) rose 2.4% to $31.03 on volume of 179,649,718 shares Vivani Medical Inc. (VANI) rose 270.3% to $3.74 on volume of 148,811,385 shares Nikola Corporation (NKLA) rose 1.7% to $0.7684 on volume of 121,...

IXHL - US Companies Moving the Markets, Evening edition
Wed, Feb 28, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Marathon Digital Holdings Inc. (MARA) rose 1.8% to $30.87 on volume of 148,760,969 shares Vivani Medical Inc. (VANI) rose 291.9% to $3.9579 on volume of 141,227,838 shares Nikola Corporation (NKLA) rose 2.6% to $0.7758 on volume of 10...

IXHL - Incannex Reports Positive Phase 2 Psi-GAD1 Clinical Trial Topline Results

2024-02-28 08:03:13 ET DENVER, Colo., Feb 28, 2024 ( 247marketnews.com )- Incannex Healthcare Inc. (NASDAQ: IXHL ) reported, this morning, positive topline results from its psilocybin in generalized anxiety disorder (GAD) Phase 2 Psi-GAD1 clinical trial, and that the trial met its p...

Next 10